ArticleKidney international reports2026
The Pathophysiological Mechanism of Beni-koji Choleste-Help or Puberulic Acid-Induced Kidney Injury.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In March 2024, kidney injury caused by some specific red yeast rice supplements was reported in Japan. By November 2024, 2628 people had visited medical facilities, making it a social problem. Many patients still show decreased estimated glomerular filtration rate. Puberulic acid was reported to be present in Beni-koji Choleste-Help toxic lots. However, the pathophysiology is not yet clarified. Here, we discovered that mitochondrial dysfunction in renal proximal tubular epithelial cells is associated with, and may contribute to, nephrotoxicity. Methods: To assess the effects of Beni-koji Choleste-Help toxic lots and puberulic acid, we performed RNA sequencing (RNA-seq), extracellular flux analysis, and other assays across multiple models, including human kidney biopsy specimens, primary human renal proximal tubular epithelial cells (hRPTECs), human renal organoids, and mice. Results: A patient renal biopsy sample showed kidney injury molecule-1 expression in proximal tubules surrounded by activated myofibroblasts, indicating tubular damage and fibrosis. Mice treated with toxic lots and puberulic acid showed kidney injury with some features of Fanconi syndrome. Pathological sections revealed tubular necrosis and fibrosis. RNA-seq analysis of whole kidneys showed that the toxic lot and puberulic acid produced similar RNA patterns, suggesting puberulic acid is a causative agent. Gene ontology (GO) analysis comparing the normal and toxic lot revealed mitochondrial pathways downregulation. Puberulic acid showed toxicity to hRPTECs and tubular organoids. Conclusion: Puberulic acid and Beni-koji Choleste-Help toxic lots cause mitochondrial damage and cell death to tubular epithelial cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.